{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:45:14Z","timestamp":1758476714073},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1053\/j.semtcvs.2015.05.003","type":"journal-article","created":{"date-parts":[[2015,6,17]],"date-time":"2015-06-17T04:38:57Z","timestamp":1434515937000},"page":"240-249","source":"Crossref","is-referenced-by-count":5,"title":["Induction Therapy for Mesothelioma"],"prefix":"10.1053","volume":"27","author":[{"given":"Isabelle","family":"Opitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Weder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1053\/j.semtcvs.2015.05.003_bib1","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1200\/JCO.2004.10.071","article-title":"Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"22","author":"Weder","year":"2004","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1053\/j.semtcvs.2015.05.003_bib2","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdm093","article-title":"Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"18","author":"Weder","year":"2007","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1053\/j.semtcvs.2015.05.003_bib3","first-page":"428","article-title":"Systematic review of trimodality therapy for patients with malignant pleural mesothelioma","volume":"1","author":"Cao","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"issue":"4","key":"10.1053\/j.semtcvs.2015.05.003_bib4","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.athoracsur.2006.12.029","article-title":"Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer","volume":"83","author":"Petersen","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1053\/j.semtcvs.2015.05.003_bib5","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/JTO.0b013e3181a5292c","article-title":"Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapy","volume":"4","author":"Gupta","year":"2009","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1053\/j.semtcvs.2015.05.003_bib6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/JTO.0b013e3181d86ea9","article-title":"Chemotherapy induced pathologic complete response in malignant pleural mesothelioma: A review and case report","volume":"5","author":"Bech","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1053\/j.semtcvs.2015.05.003_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/JTO.0b013e3181d86ea9","article-title":"Modified RECIST criteria for assessment of response in malignant pleural mesothelioma","volume":"15","author":"Byrne","year":"2004","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1053\/j.semtcvs.2015.05.003_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lungcan.2005.12.013","article-title":"Modeling of mesothelioma growth demonstrates weaknesses of current response criteria","volume":"52","author":"Oxnard","year":"2006","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1053\/j.semtcvs.2015.05.003_bib9","first-page":"1116","article-title":"LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes","volume":"57","author":"Shih","year":"1997","journal-title":"Cancer Res"},{"issue":"9","key":"10.1053\/j.semtcvs.2015.05.003_bib10","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/JTO.0b013e318260deaa","article-title":"Folylpoly-glutamate synthetase expression is associated with tumor response and outcome from pemetrexed-based chemotherapy in malignant pleural mesothelioma","volume":"7","author":"Christoph","year":"2012","journal-title":"J Thorac Oncol"},{"issue":"8","key":"10.1053\/j.semtcvs.2015.05.003_bib11","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1158\/1078-0432.CCR-10-2873","article-title":"Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed\/carboplatin","volume":"17","author":"Zucali","year":"2011","journal-title":"Clin Cancer Res."},{"issue":"9","key":"10.1053\/j.semtcvs.2015.05.003_bib12","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1200\/JCO.2009.25.9275","article-title":"Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy","volume":"28","author":"Righi","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1053\/j.semtcvs.2015.05.003_bib13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/JTO.0b013e318287c224","article-title":"Reduced folate carrier and folylpolyglutamate synthetase, but not thymidylate synthase predict survival in pemetrexed-treated patients suffering from malignant pleural mesothelioma","volume":"8","author":"Mairinger","year":"2013","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1053\/j.semtcvs.2015.05.003_bib14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/JTO.0b013e318283da3e","article-title":"Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma","volume":"8","author":"Lustgarten","year":"2013","journal-title":"J Thorac Oncol"},{"issue":"8","key":"10.1053\/j.semtcvs.2015.05.003_bib15","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/JTO.0b013e31829b1cf9","article-title":"The issue of studies evaluating biomarkers which predict outcome after pemetrexed-based chemotherapy in malignant pleural mesothelioma","volume":"8","author":"Mairinger","year":"2013","journal-title":"J Thorac Oncol"},{"issue":"8","key":"10.1053\/j.semtcvs.2015.05.003_bib16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1200\/JCO.2012.43.0900","article-title":"ERCC1 and RRM1: Ready for prime time?","volume":"31","author":"Besse","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semtcvs.2015.05.003_bib17","doi-asserted-by":"crossref","unstructured":"Frischknecht L, Meerang M, Soltermann A, et al: Importance of ERCC1 and RRM1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum based induction chemotherapy followed by surgery J Thorac Cardiovasc Surg 149(6):1539-1547.e1, 2015","DOI":"10.1016\/j.jtcvs.2015.01.065"},{"issue":"2","key":"10.1053\/j.semtcvs.2015.05.003_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cllc.2012.09.003","article-title":"Excision repair cross complementation group 1 and thymidylate synthase expression in patients with mesothelioma","volume":"14","author":"Kao","year":"2013","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"10.1053\/j.semtcvs.2015.05.003_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/JTO.0b013e318233d6a9","article-title":"Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survival","volume":"7","author":"Zimling","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.semtcvs.2015.05.003_bib20","doi-asserted-by":"crossref","unstructured":"Ting S, Mairinger FD, Hager T, et al: ERCC1, MLH1, MSH2, MSH6, and betaIII-tubulin: Resistance proteins associated with response and outcome to platinum-based chemotherapy in malignant pleural mesothelioma. Clin Lung Cancer 2013;14(5):558-67, e3","DOI":"10.1016\/j.cllc.2013.04.013"},{"issue":"15","key":"10.1053\/j.semtcvs.2015.05.003_bib21","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/cncr.28714","article-title":"A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701)","volume":"120","author":"Bepler","year":"2014","journal-title":"Cancer"},{"issue":"12","key":"10.1053\/j.semtcvs.2015.05.003_bib22","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1200\/JCO.2013.53.1525","article-title":"Customized adjuvant phase II trial in patients with non-small-cell lung cancer: IFCT-0801 TASTE","volume":"32","author":"Wislez","year":"2014","journal-title":"J Clin Oncol."},{"issue":"12","key":"10.1053\/j.semtcvs.2015.05.003_bib23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJMoa1214271","article-title":"ERCC1 isoform expression and DNA repair in non\u2013small-cell lung cancer","volume":"368","author":"Friboulet","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.semtcvs.2015.05.003_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/FPC.0b013e32834e3572","article-title":"The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma","volume":"22","author":"Erculj","year":"2012","journal-title":"Pharmacogenet Genomics"},{"issue":"6B","key":"10.1053\/j.semtcvs.2015.05.003_bib25","first-page":"3933","article-title":"ERC\/mesothelin as a marker for chemotherapeutic response in patients with mesothelioma","volume":"28","author":"Tajima","year":"2008","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1053\/j.semtcvs.2015.05.003_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.thorsurg.2007.11.004","article-title":"Risks of neoadjuvant chemotherapy and radiation therapy","volume":"18","author":"Stamatis","year":"2008","journal-title":"Thorac Surg Clin"},{"issue":"8","key":"10.1053\/j.semtcvs.2015.05.003_bib27","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: Clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semtcvs.2015.05.003_bib28","doi-asserted-by":"crossref","unstructured":"Lauk O, Hoda MA, de Perrot M, Friess M, Klikovits T, Klepetko W, et al: Extrapleural pneumonectomy after induction chemotherapy: perioperative outcome in 251 mesothelioma patients from three high-volume institutions. Ann Thorac Surg, 2014","DOI":"10.1016\/j.athoracsur.2014.05.071"},{"key":"10.1053\/j.semtcvs.2015.05.003_bib29","doi-asserted-by":"crossref","unstructured":"Rea F, Favaretto A, Marulli G, Spaggiari L, DePas MT, Ceribelli A, et al: Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma. BMC Cancer 13(1):22, 2013","DOI":"10.1186\/1471-2407-13-22"},{"key":"10.1053\/j.semtcvs.2015.05.003_bib30","doi-asserted-by":"crossref","unstructured":"Van Schil PE, Baas P, Gaafar R, Maat AP, Van de Pol M, Hasan B, et al: Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J 36(6):1362-9, 2010","DOI":"10.1183\/09031936.00039510"},{"key":"10.1053\/j.semtcvs.2015.05.003_bib31","doi-asserted-by":"crossref","unstructured":"Buduhan G, Menon S, Aye R, Louie B, Mehta V, Vallieres E: Trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 88(3):870-5(discussion 6), 2009","DOI":"10.1016\/j.athoracsur.2009.05.036"},{"key":"10.1053\/j.semtcvs.2015.05.003_bib32","unstructured":"Krug LM, Pass HI, Rusch VW, Kindler HL, Sugarbaker DJ, Rosenzweig KE, et al: Multicenterp II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009:JCO.2008.20.3943"},{"key":"10.1053\/j.semtcvs.2015.05.003_bib33","doi-asserted-by":"crossref","unstructured":"de Perrot M, Feld R, Cho BC, Bezjak A, Anraku M, Burkes R, et al: Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol 27(9):1413-8, 2009","DOI":"10.1200\/JCO.2008.17.5604"},{"issue":"4","key":"10.1053\/j.semtcvs.2015.05.003_bib34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejcts.2006.01.015","article-title":"Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"29","author":"Opitz","year":"2006","journal-title":"Eur J Cardio-Thorac"},{"issue":"10","key":"10.1053\/j.semtcvs.2015.05.003_bib35","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1097\/JTO.0b013e3181ed0489","article-title":"A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"5","author":"Cao","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1053\/j.semtcvs.2015.05.003_bib36","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1510\/icvts.2010.262972","article-title":"Staging of patients after extrapleural pneumonectomy for malignant pleural mesothelioma\u2014institutional review and current update","volume":"12","author":"Cao","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"suppl 2","key":"10.1053\/j.semtcvs.2015.05.003_bib37","first-page":"S238","article-title":"Management of malignant pleural mesothelioma-The European experience","volume":"6","author":"Opitz","year":"2014","journal-title":"J Thorac Dis"},{"issue":"2","key":"10.1053\/j.semtcvs.2015.05.003_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejcts.2006.11.008","article-title":"Induction chemotherapy does not increase the operative risk of pneumonectomy!","volume":"31","author":"Mansour","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"10.1053\/j.semtcvs.2015.05.003_bib39","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.jtcvs.2010.02.039","article-title":"Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non\u2013small-cell lung cancer","volume":"139","author":"Weder","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1053\/j.semtcvs.2015.05.003_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.hlc.2014.07.055","article-title":"Morbidity and mortality after major pulmonary resections in patients with locally advanced stage IIIA non-small cell lung carcinoma who underwent induction therapy","volume":"24","author":"Peer","year":"2015","journal-title":"Heart Lung Circ"},{"issue":"3","key":"10.1053\/j.semtcvs.2015.05.003_bib41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.lungcan.2007.01.024","article-title":"Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma","volume":"56","author":"Opitz","year":"2007","journal-title":"Lung Cancer."},{"issue":"2","key":"10.1053\/j.semtcvs.2015.05.003_bib42","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jtcvs.2014.10.041","article-title":"Pleurectomy\/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: A 10-year experience","volume":"149","author":"Lang-Lazdunski","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1053\/j.semtcvs.2015.05.003_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s005950300000","article-title":"Postoperative complications of pulmonary resection after platinum-based induction chemotherapy for primary lung cancer","volume":"33","author":"Muraoka","year":"2003","journal-title":"Surg Today"},{"issue":"1","key":"10.1053\/j.semtcvs.2015.05.003_bib44","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0003-4975(03)01487-5","article-title":"Respiratory function changes after chemotherapy: An additional risk for postoperative respiratory complications?","volume":"77","author":"Leo","year":"2004","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1053\/j.semtcvs.2015.05.003_bib45","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jtcvs.2004.02.021","article-title":"Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies","volume":"128","author":"Sugarbaker","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1053\/j.semtcvs.2015.05.003_bib46","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.athoracsur.2007.11.065","article-title":"Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"85","author":"de Perrot","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.semtcvs.2015.05.003_bib47","doi-asserted-by":"crossref","unstructured":"Burt BM, Cameron RB, Mollberg NM, Kosinski AS, Schipper PH, Shrager JB, et al: Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality. J Thorac Cardiovasc Surg 148(1):30-5, 2014","DOI":"10.1016\/j.jtcvs.2014.03.011"},{"key":"10.1053\/j.semtcvs.2015.05.003_bib48","doi-asserted-by":"crossref","unstructured":"Nakas A, von Meyenfeldt E, Lau K, Muller S, Waller D: Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma. Eur J Cardiothorac Surg 41(5):1031-6, 2012","DOI":"10.1093\/ejcts\/ezr192"},{"key":"10.1053\/j.semtcvs.2015.05.003_bib49","doi-asserted-by":"crossref","unstructured":"Rena O, Casadio C: Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: A harmful procedure. Lung Cancer 77(1):151-5, 2012","DOI":"10.1016\/j.lungcan.2011.12.009"},{"key":"10.1053\/j.semtcvs.2015.05.003_bib50","doi-asserted-by":"crossref","unstructured":"Schipper PH, Nichols FC, Thomse KM, Deschamps C, Cassivi SD, Allen MS, et al: Malignant pleural mesothelioma: surgical management in 285 patients. Ann Thorac Surg 85(1):257-64(discussion 64), 2008","DOI":"10.1016\/j.athoracsur.2007.06.066"},{"issue":"9","key":"10.1053\/j.semtcvs.2015.05.003_bib51","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1200\/JCO.2008.17.5604","article-title":"Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"27","author":"de Perrot","year":"2009","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1053\/j.semtcvs.2015.05.003_bib52","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the international association for the study of lung cancer mesothelioma database","volume":"7","author":"Rusch","year":"2012","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1053\/j.semtcvs.2015.05.003_bib53","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0022-5223(98)70274-0","article-title":"Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma","volume":"115","author":"Pass","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1053\/j.semtcvs.2015.05.003_bib54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2214\/AJR.11.7015","article-title":"Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: Stratification of survival with CT-derived tumor volume","volume":"198","author":"Gill","year":"2012","journal-title":"Am J Roentgenol"},{"issue":"3","key":"10.1053\/j.semtcvs.2015.05.003_bib55","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/JTO.0000000000000078","article-title":"A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: The SMART approach for resectable malignant pleural mesothelioma","volume":"9","author":"Cho","year":"2014","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1053\/j.semtcvs.2015.05.003_bib56","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.critrevonc.2012.09.001","article-title":"Radiation therapy and immunotherapy: Implications for a combined cancer treatment","volume":"85","author":"Levy","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"issue":"17","key":"10.1053\/j.semtcvs.2015.05.003_bib57","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1158\/1078-0432.CCR-12-1175","article-title":"Optimizing cancer treatments to induce an acute immune response: Radiation abscopal effects, PAMPs, and DAMPs","volume":"18","author":"Ludgate","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semtcvs.2015.05.003_bib58","first-page":"51","article-title":"New and emerging therapeutic options for malignant pleural mesothelioma: Review of early clinical trials","volume":"7","author":"Kotova","year":"2015","journal-title":"Cancer Manag Res"},{"issue":"10","key":"10.1053\/j.semtcvs.2015.05.003_bib59","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.leukres.2010.04.016","article-title":"BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review","volume":"34","author":"An","year":"2010","journal-title":"Leuk Res"},{"issue":"49","key":"10.1053\/j.semtcvs.2015.05.003_bib60","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1038\/sj.onc.1203912","article-title":"Role of Src expression and activation in human cancer","volume":"19","author":"Irby","year":"2000","journal-title":"Oncogene"},{"key":"10.1053\/j.semtcvs.2015.05.003_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/1-4020-7847-1_6","article-title":"Basis and importance of Src as a target in cancer","volume":"119","author":"Levin","year":"2004","journal-title":"Cancer Treat Res"},{"issue":"7","key":"10.1053\/j.semtcvs.2015.05.003_bib62","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1158\/1535-7163.MCT-07-0052","article-title":"Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion","volume":"6","author":"Tsao","year":"2007","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"10.1053\/j.semtcvs.2015.05.003_bib63","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/JTO.0b013e318248242c","article-title":"Phase II study of dasatinib in patients with previously treated malignant mesothelioma (cancer and leukemia group B 30601): A brief report","volume":"7","author":"Dudek","year":"2012","journal-title":"J Thorac Oncol"},{"issue":"15s","key":"10.1053\/j.semtcvs.2015.05.003_bib64","article-title":"Evaluation of Src Tyr 419 as a predictive biomarker in a neoadjuvant trial using dasatinib in resectable malignant pleural mesothelioma","volume":"28","author":"Tsao","year":"2010","journal-title":"J Clin Oncol"},{"issue":"237","key":"10.1053\/j.semtcvs.2015.05.003_bib65","doi-asserted-by":"crossref","first-page":"237ra68","DOI":"10.1126\/scitranslmed.3008639","article-title":"Merlin deficiency predicts FAK inhibitor sensitivity: A synthetic lethal relationship","volume":"6","author":"Shapiro","year":"2014","journal-title":"Sci Transl Med"}],"container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067915000908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067915000908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T03:33:12Z","timestamp":1566876792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043067915000908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"alternative-id":["S1043067915000908"],"URL":"https:\/\/doi.org\/10.1053\/j.semtcvs.2015.05.003","relation":{},"ISSN":["1043-0679"],"issn-type":[{"value":"1043-0679","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}